Original language | English |
---|---|
Pages (from-to) | 925-926 |
Number of pages | 2 |
Journal | Nature Methods |
Volume | 10 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2013 |
Bibliographical note
Funding Information:This work was funded by the Biotechnology and Biological Sciences Research Council, Leukaemia and Lymphoma Research, the Medical Research Council (MRC), Cancer Research UK, the Cambridge National Institute for Health Research (NIHR) Biomedical Research Center and core support grants from the Wellcome Trust–MRC Cambridge Stem Cell Institute. F.S.L.N. is supported by a Yousef Jameel scholarship.
Funding Information:
This work was supported in part by US National Institutes of Health grant 1RO1 GM085022 and US National Science Foundation awards DBI-0965316 and I-Corps 1242525 to Z.B.-J.
Funding
This work was funded by the Biotechnology and Biological Sciences Research Council, Leukaemia and Lymphoma Research, the Medical Research Council (MRC), Cancer Research UK, the Cambridge National Institute for Health Research (NIHR) Biomedical Research Center and core support grants from the Wellcome Trust–MRC Cambridge Stem Cell Institute. F.S.L.N. is supported by a Yousef Jameel scholarship. This work was supported in part by US National Institutes of Health grant 1RO1 GM085022 and US National Science Foundation awards DBI-0965316 and I-Corps 1242525 to Z.B.-J.
Funders | Funder number |
---|---|
Cambridge National Institute for Health Research | |
US National Institutes of Health | 1RO1 GM085022 |
National Science Foundation | DBI-0965316, I-Corps 1242525 |
National Institute on Handicapped Research | |
Wellcome Trust | |
Seventh Framework Programme | 242763 |
Medical Research Council | |
Biotechnology and Biological Sciences Research Council | |
Cancer Research UK | |
Leukaemia and Lymphoma Research |